|View printer-friendly version|
MiMedx Announces Leadership Changes And Corporate Actions
These resignations, which follow the recent departures of the Company's Chief Financial Officer and Corporate Controller and Treasurer, are based on the Board of Directors' business judgment regarding the Company's leadership and direction, and arise, in part, from information the Audit Committee has identified through its previously announced independent investigation. This investigation is ongoing and there may be other actions taken based, at least in part, on information from the investigation.
The MiMedx Board of Directors has named
Mr. Evans has been a member of the MiMedx Board of Directors since
The Board has also appointed
Mr. Coles is a Managing Director with
"The Board is confident that now is the right time for
Mr. Coles commented, "I am honored to join
The Board of Directors has commenced a search to identify and evaluate internal and external candidates to serve as permanent CEO.
Update on Corporate Compliance and Operations Initiatives
The Board has taken a number of actions to promote accountability and strengthen oversight, and is supporting Company management in the development and implementation of measures to improve
As previously announced, the Audit Committee of the Company's Board of Directors concluded that the Company's previously issued financial statements relating to each of the fiscal years ended
Also as previously announced, the Company received a subpoena last year from the
Safe Harbor Statement
This press release includes forward-looking statements. Additional forward-looking statements may be identified by words such as "believe," "expect," "may," "plan," "potential," "will," "preliminary," and similar expressions, and are based on management's current beliefs and expectations. Forward-looking statements are subject to risks and uncertainties, and the Company cautions investors against placing undue reliance on such statements.
Actual results may differ from those set forth in the forward-looking statements. For more detailed information on the risks and uncertainties, please review the Risk Factors section of the Company's most recent annual report or quarterly report filed with the
Robert P. Borchert, Vice President, Investor Relations, 770-651-9383, email@example.com